
Please try another search
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. The company offers medical/healthcare products, including BELLOCEA S7, a spherical cellulose acetate particle; FLAVOCELL S-Equol; Urolithin A; polyglycerols; konjac ceramide; excipients for foods; chiral columns and reagents; and Actranza lab, as well as separation and analytical services. It also provides performance films, solvents for electronic materials, cycloaliphatic epoxies, polymers for photoresists, optical lenses, and caprolactone derivatives; functional films and materials used in smartphones, PCs, TVs, and in-vehicle displays, polymers and solvents; and lenses used in VR, smartphones and various sensors. In addition, the company offers airbags inflators, pyro-fuses, and gas generators for seat belt pretensioners; acetic acid, acetic acid derivatives, acetate tow, ketene / diketene derivatives, cellulose acetate for LCD optical films, amines, and 1,3-butylene glycol; and reverse osmosis membrane and ultrafiltration membrane products, as well as water treatment systems. Further, it provides Engineering plastics comprising polyacetal, polybutylene terephthalate, polyphenylene sulfide, liquid crystal polymer, and cyclic olefin copolymer; AS resin, acetate plastics, water-soluble polymers, and barrier films for packaging; ABS resins, various polymer alloys, plastic compounds; Polyamide-12 and PEEK resin; and various molded containers. The company’s products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and is headquartered in Osaka, Japan.
Name | Age | Since | Title |
---|---|---|---|
Toshio Asano | - | 2019 | Independent External Director |
Hideo Makuta | - | - | Outside Audit & Supervisory Board Member |
Yuriya Komatsu | - | 2022 | Independent Outside Director |
Yasuhiro Sakaki | 63 | 2019 | President, CEO & Director |
Mikio Yagi | 64 | 2023 | Standing Audit & Supervisory Board Chairman |
Junichi Mizuo | 78 | 2018 | Outside Audit & Supervisory Board Member |
Teisuke Kitayama | 79 | 2018 | Independent External Director |
Hisae Kitayama | 68 | 2022 | Outside Audit & Supervisory Board Member |
Yoshimi Ogawa | 65 | 2011 | Board Chairman |
Hideo Makuta | 72 | 2020 | Outside Audit & Supervisory Board Member |
Keita Nishiyama | 62 | 2023 | Independent Outside Director |
Toshio Asano | 73 | 2019 | Independent External Director |
Seiji Kito | 63 | 2025 | Independent Outside Director |
Toshio Shiwaku | 62 | 2024 | Senior Managing Executive Officer & Director |
Naotaka Kawaguchi | 64 | 2024 | Senior Managing Executive Officer, Senior Managing Executive Officer & Director & Director |
Kotaro Sugimoto | 65 | 2019 | Senior Managing Exec. Officer, Head of Corp. Support HQ & Representative Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review